Cinctive Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Cinctive Capital Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,350	Closed	-$1.01M	–	452
2026 Q1	$1.01M	Sell	25,350 -47,481	-65%	-$1.21M	0.07%	252
2025 Q4	$1.82M	Sell	72,831 -19,797	-21%	-$501K	0.1%	225
2025 Q3	$2.25M	Buy	+92,628	New	+$1.65M	0.11%	243

Cinctive Capital Management's CNTA Position: Q2 2026 in Review

Cinctive Capital Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 25,350 shares — an estimated $1.01M sold.

Cinctive Capital Management first reported a position in CNTA in Q3 2025 and held it in 3 quarters. The position peaked at $2.25M in Q3 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Cinctive Capital Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Cinctive Capital Management sold 25,350 Centessa Pharmaceuticals shares in Q2 2026, an estimated $1.01M.
Cinctive Capital Management first reported a position in Centessa Pharmaceuticals in Q3 2025 and held it in 3 quarters.
Cinctive Capital Management's Centessa Pharmaceuticals position peaked at $2.25M in Q3 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.